Not exact matches
The Kamens claim the main thing that distinguishes their foundation from other
brain tumor foundations is their focus on
pediatric brain cancer specifically, as well as their close ties
with pharmaceutical and biotech companies working in the fields of immunotherapy and target gene therapy.
MaxLove Project, Cloud b & 130 SuperKids Around the World Join Forces
with SuperMax the Turtle In Unified Day of Giving to Empower Children & Raise Funds for
Cancer Research and Treatment (Santa Ana, CA) May 5, 2015 — Today, in conjunction with Brain Cancer Awareness Month, 130 pediatric cancer survivors will be delivering care -LS
Cancer Research and Treatment (Santa Ana, CA) May 5, 2015 — Today, in conjunction
with Brain Cancer Awareness Month, 130 pediatric cancer survivors will be delivering care -LS
Cancer Awareness Month, 130
pediatric cancer survivors will be delivering care -LS
cancer survivors will be delivering care -LSB-...]
Researchers investigating
pediatric low - grade gliomas (PLGG), the most common type of
brain tumor in children, have discovered key biological differences in how mutated genes combine
with other genes to drive this childhood
cancer.
This research, for instance, helped identify a histone methylation inhibitor as the first therapeutic candidate for
pediatric ependymoma, a common childhood
brain cancer (work
with Michael Taylor at SickKids).
Our groundbreaking
Pediatric Mi - Oncoseq Program is an internationally known precision oncology program focusing on the genetic analysis of
pediatric cancer patients including in children
with malignant
brain tumors, and determines whether targeted treatments may be available based upon their personalized tumor genomic sequencing profiles.